DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

PTC Therapeutics, Inc. (NASDAQ: PTCT)

53.37 1.71 (3.31%)

Quote as of

Extended Hours: $53.38 $0.01 (0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PTCT $53.37 3.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.67
Previous Close $51.66
Daily Range $51.40 - $54.04
52-Week Range $14.51 - $57.50
Market Cap $1.8B
P/E Ratio -24.37
Dividend (Yield) $0.00 (0.0%)
Volume 155,699
Average Daily Volume 447,077
Current FY EPS -$3.22

Sector

Industry

PTC Therapeutics, Inc. (PTCT) Description

PTC Therapeutics, Inc. Website: http://www.ptcbio.com/

News & Commentary

3 Drugmakers Facing a Pivotal 2015

Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?

PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog

PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog

PTC Therapeutics Begins Rolling NDA Submission to the FDA for Translarna to Treat Duchenne Muscular

PTC Therapeutics Begins Rolling NDA Submission to the FDA for Translarna to Treat Duchenne Muscular Dystrophy

PTC Therapeutics (PTCT) Downgraded From Hold to Sell

Trade-Ideas: PTC Therapeutics (PTCT) Is Today's New Lifetime High Stock

Why PTC Therapeutics (PTCT) Stock Might be a Great Pick - Tale of the Tape

PTC Therapeutics, Inc. (PTCT) in Focus: Stock Gains 5.2% - Tale of the Tape

PTC Therapeutics, Inc. (PTCT) in Focus: Stock Gains 5.2% - Tale of the Tape

PTC Therapeutics Announces Launch Of Translarna In Germany

PTC Therapeutics (PTCT) Shares March Higher, Can It Continue? - Tale of the Tape

PTC Therapeutics (PTCT) Shares March Higher, Can It Continue? - Tale of the Tape

Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial In Patients With SMA

See More PTCT News...